Key facts pulled from the official settlement site; not yet independently field-verified — confirm details on the official site.
Sartan Medication Valsartan Losartan Irbesartan Settlement
Settled: $15.26M payout for consumers who purchased contaminated Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan blood pressure medications containing carcinogenic nitrosamine impurities.
Total settlement: $15.26 million. Hetero Valsartan: up to $40 per 30-day supply, maximum $120 per consumer. Aurobindo Irbesartan: up to $100 per claimant (up to $200 with proof). Vivimed Losartan: pro rata distribution based on total valid claims.
Who may qualify
You qualify if you are a U.S. resident who paid out-of-pocket for Hetero Valsartan between May-July 2018, Aurobindo Irbesartan from January 2016 onward, or specific Vivimed Losartan products. Employees and officers of defendant companies are excluded.
U.S. individuals who purchased contaminated blood pressure medications: Hetero Valsartan (May 1 - July 31, 2018), Aurobindo Irbesartan (January 1, 2016 to present), or Vivimed Losartan (specific NDC codes). Excluded: defendant companies, officers, PBMs, judges presiding over the case.
This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.
Important dates
- Claim deadline
- June 2, 2026 (closed)
- Exclusion deadline
- June 2, 2026 (passed)
- Objection deadline
- June 2, 2026 (passed)
Proof requirements
Proof requirement is currently marked as Optional.
Review the official claim form before submitting any information.
What you need
Submit claim form online or by mail by June 2, 2026 (deadline now passed). Documentation is optional but recommended to verify purchase and potentially increase payout amount.
How do I file a claim for this settlement?
This record no longer has an open public claim form — confirm the current status and any next steps on the official source.
- Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
- Gather any documents the official form asks for — this settlement marks proof as Optional.
- Open the official claim form or settlement website run by Sartan Medication Settlement Administrator, P.O. Box 3376, Baton Rouge, LA 70821; Phone: 866-875-9644; Email: info@SartanMedicationSettlement.com.
- Submit accurate information through the official settlement administrator or government source before June 2, 2026.
- Save your confirmation number if one is provided, then watch the payment status for distribution updates.
New to settlement claims? How to file safely →
Worried it might be fake? Run the 60-second legitimacy check →
How we verified this record
- Claim deadline queued for re-check
- Payout details queued for re-check
- Eligibility queued for re-check
- Proof requirement queued for re-check
- Administrator queued for re-check
- Official claim link queued for re-check
- Court case queued for re-check
- Payment status queued for re-check
Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.
Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.
Common questions
Who may qualify for this settlement?
U.S. individuals who purchased contaminated blood pressure medications: Hetero Valsartan (May 1 - July 31, 2018), Aurobindo Irbesartan (January 1, 2016 to present), or Vivimed Losartan (specific NDC codes). Excluded: defendant companies, officers, PBMs, judges presiding over the case.
What is the claim deadline?
The claim deadline is June 2, 2026. Confirm the current deadline on the official settlement source before filing.
Do I need proof to claim?
Proof requirement: Optional. The settlement administrator determines what documentation, if any, is required.
What is the current payment status?
Current payment status: Unknown. Payments are issued by the administrator after the court process concludes.
When will Sartan Medication Valsartan Losartan Irbesartan Settlement pay out?
Current payment status: Unknown. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.
Where is the official Sartan Medication Valsartan Losartan Irbesartan Settlement claim form?
The official claim form is hosted by the settlement administrator, Sartan Medication Settlement Administrator, P.O. Box 3376, Baton Rouge, LA 70821; Phone: 866-875-9644; Email: info@SartanMedicationSettlement.com. Use the 'Open official claim form' button on this page — never pay a fee to file.
What medications are covered?
Hetero Valsartan (May-July 2018), Aurobindo Irbesartan (Jan 2016-present), and Vivimed Losartan products with specific NDC codes.
Do I need proof of purchase?
No, but providing pharmacy receipts or calling your pharmacy to get prescription records can increase your payout and prevent claim delays.
What if I miss the June 2 deadline?
The claim deadline has passed as of June 9, 2026. You cannot file claims after June 2, 2026.
How much will I receive?
Depends on the manufacturer and documentation provided. Hetero: $40-120. Aurobindo: $100-200. Vivimed: pro rata share.
When will I receive my payment?
After the Final Approval Hearing (June 30, 2026) and once the settlement becomes effective, the administrator will distribute payments.
Where to act
When you are ready, you open the official claim form yourself. SettleSignal does not file claims or determine eligibility.
The claim deadline (Jun 02, 2026) has passed — this settlement is closed to new claims. Listed for reference.
Listed on the official settlement website (Sartan Medication Settlement Administrator).
Disclaimer
This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.
Change log
- June 9, 2026 — Settlement published after verification.